J Korean Neurol Assoc.
2014 Aug;32(3):186-189.
Myotonic Potentials in the Myopathy Induced by HMG-CoA Reductase Inhibitor
- Affiliations
-
- 1Department of Neurology, Hallym University College of Medicine, Anyang, Korea. hima@hallym.ac.kr
Abstract
- HMG-CoA reductase inhibitor is widely used for the treatment of dyslipidemia, and for the prevention of stroke and cardiovascular disease. However, it is necessary to consider the adverse effects associated with this drug. Myopathy is a well-known side effect of statin therapy, but myotonic potentials in cases with statin myopathy have thus far been reported only rarely. We report four cases of myopathy with myotonic potentials on electromyography after multidrug administration. All of the patients recovered shortly after statin withdrawal.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Acquired Ichthyosis Developed During Cholesterol-lowering Treatment
- The Effects of Long Term Use of HMG-CoA Reductase Inhibitor on the Level of Lp (a)
- Statin-Induced Autoimmune Necrotizing Myopathy Responsive to Immunosuppressive Therapy
- HMG CoA Reductase Inhibitors Inhibit HCV RNA Replication of HCV Genotype 1b but Not 2a
- Statin-Naïve Paraneoplastic Anti-HMGCR Myopathy
